Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
NAR Cancer
|
January 2, 2026
Uracil-DNA glycosylase deficiency is associated with repressed tumor cell-intrinsic inflammatory signaling and altered sensitivity to exogenous interferons
Frank P Vendetti, Pinakin Pandya, Carina R Sclafani, et al.
Thyroid : Official Journal of the American Thyroid Association
|
April 12, 2018
Kallikreins Stepwise Scoring Reveals Three Subtypes of Papillary Thyroid Cancer with Prognostic Implications
Raquel Buj, Izaskun Mallona, Anna Díez-Villanueva, et al.
The Journal of Cell Biology
|
May 26, 2021
DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A
Kelly E Leon, Raquel Buj, Elizabeth Lesko, et al.
The Journal of Cell Biology
|
November 18, 2022
ATM inhibition drives metabolic adaptation via induction of macropinocytosis
Zhentai Huang, Chi-Wei Chen, Raquel Buj, et al.
Biorxiv : the Preprint Server for Biology
|
July 28, 2023
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, et al.
Oncotarget
|
February 10, 2016
Quantification of unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples
Raquel Buj, Izaskun Mallona, Anna Díez-Villanueva, et al.
EMBO Reports
|
June 13, 2025
ATR promotes mTORC1 activity via de novo cholesterol synthesis
Naveen Kumar Tangudu, Alexandra N Grumet, Richard Fang, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
ATR promotes mTORC1 activity via <i>de novo</i> cholesterol synthesis
Naveen Kumar Tangudu, Alexandra N Grumet, Richard Fang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 23, 2017
Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid Cancer
Esther N Klein Hesselink, Carles Zafon, Núria Villalmanzo, et al.
Biorxiv : the Preprint Server for Biology
|
June 17, 2024
Deoxyuridine-rich cytoplasmic DNA antagonizes STING-dependent innate immune responses and sensitizes resistant tumors to anti-PD-L1 therapy
Pinakin Pandya, Frank P Vendetti, Joseph El-Ghoubaira, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
NAR Cancer
|
January 2, 2026
Uracil-DNA glycosylase deficiency is associated with repressed tumor cell-intrinsic inflammatory signaling and altered sensitivity to exogenous interferons
Frank P Vendetti, Pinakin Pandya, Carina R Sclafani, et al.
Thyroid : Official Journal of the American Thyroid Association
|
April 12, 2018
Kallikreins Stepwise Scoring Reveals Three Subtypes of Papillary Thyroid Cancer with Prognostic Implications
Raquel Buj, Izaskun Mallona, Anna Díez-Villanueva, et al.
The Journal of Cell Biology
|
May 26, 2021
DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A
Kelly E Leon, Raquel Buj, Elizabeth Lesko, et al.
The Journal of Cell Biology
|
November 18, 2022
ATM inhibition drives metabolic adaptation via induction of macropinocytosis
Zhentai Huang, Chi-Wei Chen, Raquel Buj, et al.
Biorxiv : the Preprint Server for Biology
|
July 28, 2023
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, et al.
Oncotarget
|
February 10, 2016
Quantification of unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples
Raquel Buj, Izaskun Mallona, Anna Díez-Villanueva, et al.
EMBO Reports
|
June 13, 2025
ATR promotes mTORC1 activity via de novo cholesterol synthesis
Naveen Kumar Tangudu, Alexandra N Grumet, Richard Fang, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
ATR promotes mTORC1 activity via <i>de novo</i> cholesterol synthesis
Naveen Kumar Tangudu, Alexandra N Grumet, Richard Fang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 23, 2017
Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid Cancer
Esther N Klein Hesselink, Carles Zafon, Núria Villalmanzo, et al.
Biorxiv : the Preprint Server for Biology
|
June 17, 2024
Deoxyuridine-rich cytoplasmic DNA antagonizes STING-dependent innate immune responses and sensitizes resistant tumors to anti-PD-L1 therapy
Pinakin Pandya, Frank P Vendetti, Joseph El-Ghoubaira, et al.
Page
of 3